Meetings

  • Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development – A Workshop Date: March 8, 2017 (8:00 AM Eastern)

    This one-day public workshop will examine and discuss successes, challenges, and best practices for effectively utilizing genetic information in the design and implementation of clinical trials to support the development of precision medicines, including exploring the potential advantages and disadvantages of such trials across a variety of disease areas. Topics covered could include strategies for including genetically focused populations in clinical trial design, logistical challenges in conducting genetics-based clinical trials, and mechanisms for engaging with and educating potential trial participants.
  • Deriving Drug Discovery Value from Large-Scale Genetic Bioresources: A Workshop Date: March 22, 2016 (8:30 AM Eastern)

    On March 22, 2016, the Roundtable on Translating Genomic-Based Research for Health and the Forum on Drug Discovery, Development, and Translation hosted a one day public workshop to examine and discuss how large-scale genetic data could be used to improve the likelihood of bringing effective and targeted therapies to patients. The goal of the workshop was to address how progress could be made in discovering and validating promising targets and medicines for those targets by using the data collected from large-scale genetic studies. Discussions were held with a broad array of stakeholders which included representatives from pharmaceutical and biotech companies, IT and data science companies, research institutes, investors, providers, patients, payers, and regulators.
  • Applying an Implementation Science Approach to Genomic Medicine: A Workshop Date: November 19, 2015 (8:30 AM Eastern)

    On November 19, 2015, the Roundtable on Translating Genomic-Based Research for Health will host a workshop to examine how implementation science can be applied to genomics by using existing implementation efforts to demonstrate how challenges and successes are measured, assessed, and addressed over time. The workshop goal will be to evaluate the challenges, opportunities, and best practices for integrating genomic medicine into the health care system in a way that addresses the needs of institutions, providers, and patients.
  • Genomics-Enabled Learning Health Care Systems: Gathering and Using Genomic Information to Improve Patient Care and Research - A Workshop Date: December 8, 2014 (8:30 AM Eastern)

    On December 8, 2014, the Institute of Medicine’s Roundtable on Translating Genomic-Based Research for Health hosted a workshop to examine how a variety of systems are capturing and making use of genomic data to generate knowledge that can be used to advance patient care and research. The workshop goal was to evaluate the challenges, opportunities, and best practices for knowledge-generating health care systems and to understand how genomic information can be integrated into and enable this knowledge generation. Stakeholder groups including commercial developers and health information technology professionals, clinical providers, academic researchers, patient groups, and government and health system representatives presented their perspectives and participated in discussions during the workshop.
  • Improving Genetics Education in Graduate and Continuing Health Professional Education: A Workshop Date: August 18, 2014 (8:30 AM Eastern)

    On August 18, 2014, the Institute of Medicine’s Roundtable on Translating Genomic-Based Research for Health will host a public workshop to examine pragmatic approaches to improving genetics education in both graduate and continuing health professional education. Stakeholder groups, including health care providers, graduate health professional education program representatives, professional society representatives, board examiners, and educational specialists will present their perspectives and participate in discussions.
  • Assessing Genomic Sequencing Information for Health Care Decision Making: A Workshop Date: February 3, 2014 (8:30 AM Eastern)

    The Institute of Medicine's Roundtable on Translating Genomic-Based Research for Health will host a workshop to examine how evidence for genomic applications is gathered and assessed for clinical decision-making, reimbursement decisions, and guideline development. The workshop will also address how evidence is evaluated and used to determine what secondary information should be returned to patients from genome sequencing.
  • Genomics-Enabled Drug Repurposing and Repositioning: A Workshop Date: June 24, 2013 (8:30 AM Eastern)

    This workshop to examine and discuss genomics-based approaches to repurposing existing or newly developing therapeutics. The goal of the workshop will be to assess the current landscape of drug repurposing activities in industry, academia, and government, examine enabling tools and technology, evaluate the business models and economic incentives, and advance discussions among a broad array of stakeholders which may include government officials, pharmaceutical company representatives, academic researchers, regulators, funders, and patients.
  • Conflict of Interest in Medical Innovation: Assuring Integrity while Facilitating Innovation in Medical Research: A Workshop Date: June 5, 2013 (8:30 AM Eastern)

    The Roundtable on Translating Genomic-Based Research for Health will host a workshop to examine and discuss the effect of current conflict of interest policies—both public and private—on medical innovation. Stakeholders, including government officials, pharmaceutical company representatives, academic administrators and researchers, health care providers, medical ethicists and consumers will be invited to present their perspectives and participate in discussions during the workshop.
  • Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests: A Workshop Date: February 27, 2013 (8:30 AM Eastern)

    The Roundtable on Translating Genomic-Based Research for Health will host a workshop to examine the challenges of and potential solutions for co-development of molecular tests and targeted therapeutics. Stakeholders, including in vitro diagnostic test companies, pharmaceutical companies, regulators, pathologists, providers, patients, and public and private payers, will be invited to present their perspectives and participate in discussions during the workshop.
  • Improving the Efficiency and Effectiveness of Genomic Science Translation: A Workshop Date: December 3, 2012 (8:30 AM Pacific)

    Improving the translation of genomic discoveries will require collaborative efforts among stakeholders to encourage innovative and transformational research. The Roundtable on Translating Genomic-Based Research for Health will host a workshop to examine how basic science can best be positioned to foster successful translation of early genomic discoveries. The presentations and discussions will explore the challenges in and identify potential opportunities for improving the efficacy of the translation process. Stakeholders including academic researchers, industry representatives, policy makers, and ot hers will be invited to present their perspectives.